A pronounced linear eruption with ulcerations and calcium extrusion present in a boy with a mild generalized rash clinically consistent with juvenile dermatomyositis or overlap syndrome is reported. Loss of heterozygosity (LOH) is a postzygotic mechanism by which a heterozygous somatic cell may become homozygous or hemizygous at a given gene locus. Such a mechanism can be suspected when a pronounced segmental manifestation of an acquired skin condition with a polygenic background is found to be superimposed on more or less symmetrically distributed nonsegmental lesions of the same disorder. Alternatively, such a segmental manifestation may reflect heterozygosity for a postzygotic mutation involving an additional gene locus. The severe linear lesions in our patient showed a Blaschko-linear arrangement and were superimposed on mild nonsegmental lesions of either amyopathic dermatomyositis or overlap syndrome. Either LOH or a postzygotic mutation at an additional gene locus may explain the pronounced linear involvement.

1.
Happle R: Mosaicism in human skin: understanding the patterns and mechanisms. Arch Dermatol 1993;129:1460–1470.
2.
Heid E, Grosshans E, Gonda J, Paré M, Lipsker D: Eruption Blaschko-linéaire avec biologie lupique. Ann Dermatol Venereol 1996;123:331–333.
3.
Beek CH, Jantzen MRS: On acute linear dermatoses. Acta Dermatol Venereol 1995;35:318–325.
4.
Innocenzi D, Prandeda G, Giombini S, Silipo V, Bottoni U, Calvieri S: Linear lupus erythematosus profundus in an adolescent. Eur J Dermatol 1997;7:445–447.
5.
Taieb A, El Youbi A, Grosshans E, Maleville J: Lichen striatus: a Blaschko-linear acquired inflammatory skin eruption. J Am Acad Dermatol 1991;25:637–642.
6.
Kaidbey KH, Kurban AK: Dermatitic epidermal nevus. Arch Dermatol 1971;104:166–171.
7.
Taieb A: Linear atopic dermatitis (‘naevus atopicus’): a pathogenetic clue. Br J Dermatol 1994;131:134–135.
8.
Turner RJ, Dahl MGC, Shuster S, Rees JL: Mosaic atopic eczema cured by autotransplantation? Lancet 1998;352:961.
9.
Fink-Puches R, Hofmann-Wellenhof R, Smolle J: Zosteriform lichen planus. Dermatology 1996;192:375–377.
10.
Long CC, Finlay AY: Multiple linear lichen planus in the lines of Blaschko. Br J Dermatol 1996;135:275–276.
11.
Saxena AK, Nigam PK: Unilateral lichen planus. Cutis 1988;42:142–143.
12.
Irgang S: Zosteriform lichen planus (case report). Cutis 1968;4:1076–1078.
13.
Sigal-Nahum M: Linear fixed drug eruption (correspondence). Br J Dermatol 1988;118:849–851.
14.
Baselga E, Drolet BA, Segura AD, Leonardi CL, Esterly NB: Dermatomal lichenoid chronic graft-vs-host disease following varicella-zoster infection despite absence of viral genome. J Cutan Pathol 1996;23:576–581.
15.
Wilson BB: Linear lichenoid graft vs host disease. Arch Dermatol 1994;130:1206–1207.
16.
Reisfeld PL: Lichenoid chronic graft-vs-host disease. Arch Dermatol 1994;130:1207–1208.
17.
Beers B, Kalish RS, Kaye VN, Dahl M: Unilateral linear lichenoid eruption after bone marrow transpantation: an unmasking of tolerance to an abnormal keratinocyte clone? J Am Acad Dermatol 1993;28:888–892.
18.
Al-Fouzan AS, Hassab-El-Naby HMM, Nanda A: Congenital linear psoriasis: a case report. Pediatr Dermatol 1990;7:303–306.
19.
Atherton DJ, Kahana M, Russell-Jones R: Naevoid psoriasis. Br J Dermatol 1989;120:837–841.
20.
Wollenberg A, Baumann L, Plewig G: Linear atrophoderma of Moulin: a disease which follows Blaschko’s lines. Br J Dermatol 1996;135:277–279.
21.
Rongioletti F, Rebora A: Blaschkite de l’adulte. Ann Dermatol Venereol 1992;119:45–48.
22.
Betti R, Lodi A, Crosti C: Un autre cas de blaschkite chez l’adulte. Ann Dermatol Venereol 1992;119:577.
23.
Grosshans E, Marot L: Blaschkite de l’adulte. Ann Dermatol Venereol 1990;117:9–15.
24.
Happle R: Somatic recombination may explain linear psoriasis. J Med Genet 1991;28:337.
25.
Happle R: Loss of heterozygosity in human skin. J Am Acad Dermatol 1999;41:143–161.
26.
Happle R: Superimposed segmental manifestation of polygenic skin disorders. J Am Acad Dermatol 2007;57:690–699.
27.
Jackson R: The lines of Blaschko: a review and reconsideration – observations of the cause of certain unusual linear conditions of the skin. Br J Dermatol 1976;95:349–360.
28.
Dupré A, Viraben R, Bonafé JL, Touron P, Lamon P: Zebra-like dermatomyositis. Arch Dermatol 1981;117:63–64.
29.
Ferrer M, Herranz P, Manzano R, Fernandez-Díaz ML, de Lucas R, Casado M: Dermatomyositis with linear lesions. Br J Dermatol 1996;134:600–601.
30.
Blane CE, White SJ, Braunstein EM, Bowyer SL, Sullivan DB: Patterns of calcification in childhood dermatomyositis. AJR Am J Roentgenol 1984;142:397–400.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.